To determine the correlation between the estrogen-receptor status and responses to chemotherapy or hormonal therapy, we retrospectively analyzed the clinical data of 143 patients with advanced breast cancer. Receptor contents were determined by a sucrose-gradient method and designated arbitrarily as "rich" or "poor". The response rate to chemotherapy was significantly higher in receptor-rich tumors (86 per cent) than in receptor-poor tumors (36 per cent) (P less than 0.001). Patients with receptor-rich tumors also responded favorably to hormonal therapy. However, there was no correlation between the responses to hormonal therapy and to chemotherapy when they were used sequentially, a phenomenon that may be attributed to the changes in tumor receptor content during the clinical course. These data suggest that separate factors associated with the response to chemotherapy may coexist with estrogen receptors in breast cancer.
This article has been cited by other articles:
Colleoni, M., Viale, G., Zahrieh, D., Pruneri, G., Gentilini, O., Veronesi, P., Gelber, R. D., Curigliano, G., Torrisi, R., Luini, A., Intra, M., Galimberti, V., Renne, G., Nole, F., Peruzzotti, G., Goldhirsch, A.
(2004). Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors: A Study of Preoperative Treatment. Clin. Cancer Res.
10: 6622-6628
[Abstract][Full Text]
Colleoni, M., Gelber, S., Coates, A. S., Castiglione-Gertsch, M., Gelber, R. D., Price, K., Rudenstam, C.-M., Lindtner, J., Collins, J., Thurlimann, B., Holmberg, S. B., Cortes-Funes, H., Simoncini, E., Murray, E., Fey, M., Goldhirsch, A.
(2001). Influence of Endocrine-Related Factors on Response to Perioperative Chemotherapy for Patients With Node-Negative Breast Cancer. JCO
19: 4141-4149
[Abstract][Full Text]
Colleoni, M., Bonetti, M., Coates, A. S., Castiglione-Gertsch, M., Gelber, R. D., Price, K., Rudenstam, C.-M., Lindtner, J., Collins, J., Thurlimann, B., Holmberg, S., Veronesi, A., Marini, G., Goldhirsch, A.
(2000). Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen Receptors. JCO
18: 584-584
[Abstract][Full Text]
Chang, J., Powles, T. J., Allred, D. C., Ashley, S. E., Clark, G. M., Makris, A., Assersohn, L., Gregory, R. K., Osborne, C. K., Dowsett, M.
(1999). Biologic Markers as Predictors of Clinical Outcome From Systemic Therapy for Primary Operable Breast Cancer. JCO
17: 3058-3063
[Abstract][Full Text]
Kiang, D., King, M, Zhang, H., Kennedy, B., Wang, N
(1982). Cyclic biological expression in mouse mammary tumors. Science
216: 68-70
[Abstract]
Previous
